Edoardo Cignoli : Lilly Diabetes Drug Comparable to Market Leader

Lilly said an experimental, once-weekly drug for Type 2 diabetes was comparable to Novo Nordisk's once-daily Victoza in reducing a measure of blood sugar in a patient study.



via WSJ.com: US Business http://ift.tt/1cjpQD5